Genomic insight into a novel actinobacterium, Actinomadura rubrisoli sp. nov., reveals high potential for bioactive metabolites.
Genomic insight into a novel actinobacterium, Actinomadura rubrisoli sp. nov., reveals high potential for bioactive metabolites.
复制标题
对一种新型放线菌(Actinomadura rubrisoli sp)的基因组见解。
DOI:
10.1007/s10482-020-01511-5
复制
发表时间:
2021
期刊:
影响因子:
--
通讯作者:
Ay H
中科院分区:
文献类型:
--
作者:
Ay H
Isolation of novel actinobacteria from unexplored habitats as potential sources of novel drug leads has utmost importance. During the course of screening arid soil samples for novel actinobacteria, strain H3C3Twas isolated from Malatya, Turkey and its taxonomic position was revealed by a genome-based polyphasic approach. Pairwise sequence comparison of the 16S rRNA gene showed that the strain is closely related toActinomadura fibrosaJCM 9371Twith sequence identity level of 99.0%. Comparative genome analyses based on digital DNA-DNA hybridization and average nucleotide identity indicated that strain H3C3Trepresents a novel species within the genusActinomadura. The strain has typical characteristics of the genusActinomadura, i.e. meso-diaminopimelic acid as diagnostic amino acid; galactose, glucose, madurose and ribose as whole-cell sugars. Major menaquinones detected were MK-9(H6), MK-9(H8) and polar lipids were diphosphatidylglycerol, phosphatidylinositol, glycophospholipid and unknown phospholipid and lipids. Its genome size is approximately 10.2 Mb with G+C content of 71.6%. Further genomic analyses of strain H3C3Tindicated its high potential for novel biosynthetic gene clusters coding for various chemical structures. On the basis of phenotypic and phylogenetic analyses, strain H3C3Trepresents a novel species of the genusActinomadura, for whichActinomadura rubrisolisp. nov. is proposed, and it holds high promise for novel biosynthetic metabolites of value to biopharmaceutical industry.